Ovid Therapeutics
OVID
OVID
64 hedge funds and large institutions have $163M invested in Ovid Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-5
Holders Change %
-7.25%
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
18
Reduced
20
Closed
9
Calls
$107K
Puts
–
Net Calls
+$107K
Net Calls Change
-$4K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$6.01M |
| 2 |
MAP
Madison Avenue Partners
New York
|
+$1.31M |
| 3 |
BlackRock
New York
|
+$431K |
| 4 |
State Street
Boston,
Massachusetts
|
+$317K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$258K |
